These results indicate that BRD4 inhibitors promote adenovirus cell killing and replication not only in tumour cells but also in tumour-associated fibroblasts that are in close contact with cancer cells and suggest that the TME can be modified by these combinations to favor access of drugs, viruses, and immune cell infiltration. This evidence concerns the gene BRD4 and cancer.